Cargando cotizaciones...

Previsión

El precio objetivo medio de los analistas es de 2,09 € (-31,92 %). La mediana es de 2,09 € (-31,92 %).

Comprar
  3
Mantener
  9
Vender
  3

Debates en la comunidad

Todavía no hay ninguna discusión sobre este activo.

Iniciar debate

  • Cronos Group hits 52-week high after strong Q2 results

    The Cronos Group share rose to a 52-week high of $3.44, with a market capitalization of $1.25 billion and year-to-date performance of 25.86%. InvestingPro points to an overvaluation versus fair value. Cronos beat expectations in Q2 2026 with revenue of $53 million (expectation $44.73 million), adjusted EPS of $0.09 (expectation $0.01), gross profit of $28.5 million and adjusted EBITDA of $13.1 million; cash and investments amounted to $827 million, and $60 million in share buybacks were reported. » Más en de.investing.com


  • Cronos shares rise after Q2 results significantly beat expectations

    Cronos reported Q2 EPS of $0.09 (consensus $0.01) and revenue of $53.0 million versus expected $44.73 million. The company reported record net revenue, gross profit and adjusted EBITDA, organic revenue growth of 51% and record sales in Israel, Canada and Germany. Cronos repurchased a total of 12.3 million shares in H1 2026. The strong company-specific metrics pushed the stock sharply higher in pre-market trading and brought it closer to its 52-week high. » Más en de.investing.com


  • Cronos Group names ATB Capital Markets as broker for share buyback program

    Cronos Group has appointed ATB Capital Markets Corp. (ATB Cormark) as broker for share repurchases on the Toronto Stock Exchange and other Canadian trading systems, replacing Virtu Canada Corp. The company gave no details on the reasons, size or timing of the buyback program. Cronos has most recently pursued an aggressive buyback strategy, which coincided with a 49% share price increase last year; market capitalization is around USD 1.04 billion. » Más en de.investing.com


  • Cronos Group well above Q1 2026 forecasts; shares rise premarket

    Cronos Group reported Q1 2026 EPS of $0.04 (expectation $0.02) and revenue of CAD 45.2 million, up 40% year over year. Gross profit rose to CAD 19.2 million, adjusted EBITDA to CAD 5.1 million, and the balance sheet remains debt-free. Growth was driven mainly by stronger sales in Canada and Israel. After the results, the stock climbed about 9.45% in premarket trading. » Más en de.investing.com


  • Cronos to release results for quarter ended 31 March 2026 on 11 May 2026

    Cronos will publish results for the quarter ended 31 March 2026 on 11 May 2026. Two analysts expect earnings per share of an average of 0.005 USD, after 0.030 CAD in the year‑ago quarter. Three analysts see revenue in the report at about 42.2 million USD versus 46.3 million CAD a year earlier. Four analysts expect, on average, earnings per share of 0.060 USD and revenue of about 191.2 million USD for the current fiscal year (prior year 204.8 million CAD). » Más en finanzen.net

Datos financieros de la empresa

En el último trimestre, Cronos tuvo unos ingresos de 56,02 M € y un beneficio neto de 12,19 M €
(EUR) septiembre de 2026
YoY
Ingresos 56,02 M 80,90 %
Beneficio bruto 28,5 M 82,45 %
Beneficio neto 12,19 M 44,90 %
EBITDA 16,85 M 35,26 %

Datos fundamentales

Métrica Valor
Capitalización bursátil
1123,3 M €
Número de acciones
366,47 M
Máximo/mínimo de 52 semanas
3,55 € - 2,07 €
Dividendos No
Beta
1,20
Ratio P/E
21,01
Ratio PEG
-0,01
Ratio P/B
1,16
Ratio P/S
6,00

Perfil de la empresa

Cronos Group Inc. opera como empresa de cannabinoides. Fabrica, comercializa y distribuye suplementos y productos cosméticos de cáñamo a través de canales de comercio electrónico, venta minorista y socios del sector hostelero, bajo las marcas Lord Jones y Happy Dance en Estados Unidos. La empresa también participa en el cultivo, la fabricación y la comercialización de cannabis y productos derivados del cannabis para los mercados médico y de uso adulto. Vende cannabis y productos de cannabis, entre ellos cannabis seco, pre-rolls, comestibles, concentrados y extractos de cannabis, a través de canales mayoristas y directos al cliente bajo su plataforma de bienestar, PEACE NATURALS; y opera con las marcas de uso adulto Spinach. También exporta cannabis seco y aceites de cannabis a Alemania, Israel y Australia. Cronos Group Inc. fue fundada en 2012 y tiene su sede en Toronto, Canadá.

Nombre
Cronos
CEO
Michael Ryan Gorenstein
Sede Stayner, on
Canadá
Sitio web
Sector
Salud
Industria
Proveedores y servicios sanitarios
Salida a bolsa
27/02/2018
Empleados 610

Símbolos bursátiles

Bolsa Símbolo
NASDAQ
CRON
Toronto Stock Exchange
CRON.TO
Frankfurt
7CI.F
Düsseldorf
7CI.DU
München
7CI.MU
🍪

Parqet  usa cookies. Más información